Literature DB >> 1378984

Immunohistochemical staining patterns of tenascin in invasive breast carcinomas.

T Shoji1, T Kamiya, A Tsubura, T Hatano, T Sakakura, M Yamamoto, S Morii.   

Abstract

Eighty-two cases of primary invasive breast carcinoma and adjacent "normal" mammary glands were examined immunohistochemically for tenascin expression and distribution. Formalin-fixed tissues pretreated with actinase were processed by the avidin-biotin complex method using anti-human tenascin monoclonal antibody (RBC1). In normal mammary glands, tenascin was distributed around the ducts and ductules but not around the acini. In carcinomas, a high incidence of tenascin-positive cases (greater than 67%) was seen with various histological appearances, with the exception of lobular carcinoma where a low incidence was found (25%). Although intense staining was seen around cancerous foci when compared with normal mammary glands, tenascin was often expressed at cancer-mesenchymal junctions with dense fibrotic stroma, but not at junctions with active inflammatory change and a loose fibrotic stroma. Tenascin, expression is not an all-or-none marker for mammary malignancy and the staining pattern suggests either a role in stimulating cancer cells or a host defence mechanism accompanied by a desmoplastic response to them.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378984     DOI: 10.1007/bf01607139

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  13 in total

Review 1.  Tenascin in mammary gland development: from embryogenesis to carcinogenesis.

Authors:  T Sakakura; A Ishihara; R Yatani
Journal:  Cancer Treat Res       Date:  1991

Review 2.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors.

Authors:  H P Erickson; M A Bourdon
Journal:  Annu Rev Cell Biol       Date:  1989

3.  Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments.

Authors:  J Spring; K Beck; R Chiquet-Ehrismann
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  Tenascin expression in the human endometrium and in endometrial adenocarcinomas.

Authors:  G Vollmer; G P Siegal; R Chiquet-Ehrismann; V A Lightner; H Arnholdt; R Knuppen
Journal:  Lab Invest       Date:  1990-06       Impact factor: 5.662

5.  Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma.

Authors:  J E Ferguson; A M Schor; A Howell; M W Ferguson
Journal:  Differentiation       Date:  1990-02       Impact factor: 3.880

6.  The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia.

Authors:  R Anbazhagan; T Sakakura; B A Gusterson
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

7.  Immunohistochemical demonstration of keratins 8 and 14 in benign tumours of the skin appendage.

Authors:  A Tsubura; H Okada; M Sasaki; S H Dairkee; S Morii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.

Authors:  A A Howeedy; I Virtanen; L Laitinen; N S Gould; G K Koukoulis; V E Gould
Journal:  Lab Invest       Date:  1990-12       Impact factor: 5.662

9.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis.

Authors:  Y Inaguma; M Kusakabe; E J Mackie; C A Pearson; R Chiquet-Ehrismann; T Sakakura
Journal:  Dev Biol       Date:  1988-08       Impact factor: 3.582

10.  Immunohistochemical localization of myoepithelial cells and basement membrane in normal, benign and malignant human breast lesions.

Authors:  A Tsubura; N Shikata; T Inui; S Morii; T Hatano; T Oikawa; A Matsuzawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
View more
  6 in total

1.  A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome.

Authors:  Zhi Zeng; Marina Hincapie; Sharon J Pitteri; Samir Hanash; Joost Schalkwijk; Jason M Hogan; Hong Wang; William S Hancock
Journal:  Anal Chem       Date:  2011-05-23       Impact factor: 6.986

2.  Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures.

Authors:  A M Tokés; S Paku; S Tóth; E Paál; J Kulka; J Tóth; A Telekes
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Tenascin expression in normal human adult skin and skin appendage tumours.

Authors:  N Shikata; T Oyaizu; H Andachi; A Tsubura
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach.

Authors:  O Tiitta; P Sipponen; V Gould; I Virtanen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 5.  Tenascin C in metastasis: A view from the invasive front.

Authors:  Camille M Lowy; Thordur Oskarsson
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

6.  Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.

Authors:  Y Ikeda; M Mori; K Kajiyama; Y Haraguchi; O Sasaki; K Sugimachi
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.